Severe Anemia Due to Parvovirus Infection Following Treatment with Rituximab in a Pediatric Kidney Transplant Recipient : Anemia after Treatment of Rituximab in Kidney Recipient Patient

• Main Authors: Seung Yun Kim (Author), Hyoung Jin Lee (Author), Eujin Park (Author), Yo Han Ahn (Author), Il-Soo Ha (Author), Hae Il Cheong (Author), Hee Gyung Kang (Author)
• Format: Book
• Published: Korean Society of Pediatric Nephrology, 2015-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Rituximab (RTX), a monoclonal antibody against the B-cell marker CD20, is commonly used as a treatment for antibody-mediated diseases or B-lymphocyte-mediated diseases. Destruction of B cells may reverse the disease course in many conditions; however, patients who are treated with RTX cannot respond...